Foodborne disease is a major public health problem. The present study examined Annona squamosa leaves, which are traditionally used to treat diarrhea and other infections, for their potential to be used in modern food safety or medicine. Active constituents were partially purified by ethanol extraction and column chromatography. MICs of the extract were 62.5 to 125 μg/mL against Bacillus cereus, Listeria monocytogenes and Staphylococcus aureus, and 250 μg/mL against Campylobacter jejuni. In time-kill assays, 500 μg/mL of the extract reduced colony forming unit numbers of C. jejuni almost 10 000-fold within 12 hours. Similar decreases were seen against B. cereus, but over a longer time-frame. LC-MS analysis indicated the presence of reticuline and oxophoebine. Assessment of stability by MIC assay showed activity was heat-labile, with loss of activity greatest following high temperature treatments. Activity was relatively stable at refrigeration temperature. These results indicate A. squamosa has broad-spectrum but heat-labile activity against foodborne bacterial pathogens, and bactericidal activity against B. cereus and C. jejuni. This bactericidal activity is not sufficiently rapid for A. squamosa to be used as a food sanitizer, but the extract could potentially be developed as an additive for refrigerated foods, or a modern treatment for foodborne illness.
Foodborne disease is a significant public health problem, affecting one third of people living in industrialized countries annually, and an even larger proportion of those living in developing countries [1] . Common bacterial causes include Bacillus cereus, Listeria spp., Staphylococcus aureus, Campylobacter jejuni, Escherichia coli, and Salmonella spp. [2] . Infection typically results in mild to severe vomiting or diarrhea, but complications such as hemorrhagic colitis, meningitis, and kidney failure can occur when the bacterial strain is particularly virulent or the patient particularly susceptible [2] . Those at greatest risk of life-threatening complications include pregnant women and their unborn babies, infants, elderly adults, and people with weakened immune systems e.g. those with HIV/AIDS or cancer [3] .
Strategies to reduce morbidity and mortality from foodborne pathogens may be classified as either preventive or therapeutic. For many years, a key preventive strategy was the use of antibiotics to control pathogens in food animals, but this has contributed to the widespread emergence of antibiotic resistance [4] . Other measures to prevent foodborne illness are also hampered by problems. For example, the use of water to wash bacteria from fresh produce has negative environmental consequences [5] , and the use of antimicrobial food additives like sodium benzoate has been called into question due to health concerns [6] . To make the current predicament worse, therapeutic options for persons who succumb to foodborne illness are decreasing due to antibiotic resistance [7] .
To address these problems, efforts are being made to develop new methods of improving food safety and new treatments for foodborne illness. One avenue of research attracting increasing attention from specialists in both food safety and chemotherapeutics is that of plant-origin antimicrobials [8, 9] . These are compounds such as alkaloids, flavonoids, and saponins, which, in situ, protect plants against microbial disease [10] . Plant species from the tropics have been proposed to be a particularly rich source of active agents because of the constant chemical innovation required to survive in these highly competitive ecosystems [11] . Potential applications for antibacterial extracts and isolated compounds include food additives [12] , food sanitizers [13] , and anti-infective therapies [9] .
Annona squamosa Linn. (Annonaceae) is a small deciduous tree found throughout the lowland tropics. Its leaves are traditionally used in the treatment and prevention of various infections including GI tract infections, and have recently been reported to possess antibacterial activity [14] . In the present study, we examined this activity to establish if A. squamosa could be useful in modern food safety or medicine. Spectrum of activity was determined first, since broad spectrum activity at low concentrations is a requirement for both food and medical applications. Next, A. squamosa was examined for bactericidal activity. Agents which kill bacteria are preferable to those that just inhibit growth, and food sanitizers typically kill bacteria within ≤15 min [15] . Lastly, extract stability was assessed. Stability during storage is a requirement for most applications, and heat-stability is desirable for food additives.
Ethanol extraction and column chromatography of A. squamosa leaves yielded eight fractions and the fraction with broadest spectrum activity (see Supplementary data) was selected for further analysis. MICs of this fractionated extract were 62.5 to 125 μg/mL against S. aureus, B. cereus and L. monocytogenes (Table 1) . At 250 μg/mL, the MIC for C. jejuni was slightly higher but still within the range considered to be of practical value [9] . This lower level of activity against C. jejuni, and the absence of activity against E. coli and S. ser. Typhimurium is likely due to permeability problems posed by the double membrane of the Gram negative cell envelope. Comparison of these MICs with those of the total extract (Table 1) 
Note: MICs tested up to a maximum concentration of 2000 μg/mL and MBCs tested up to a maximum concentration of 8xMIC; -, no activity detected show fractionation improved activity. MICs for the reference standard gentamicin match those reported in the literature [16] .
Analysis of the fractionated extract by liquid chromatography/diode array detector-atmospheric pressure chemical ionization/mass spectrometry (LC/DAD-APCI/MS) indicated the presence of two major constituents, oxophoebine and reticuline. Oxophoebine is an oxoaporphine alkaloid, a subclass of the alkaloids. In a review by Kubitzki [17] , it was reported that plant species in the Annonaceae family contain many benzylisoquinoline-derived alkaloid types, chiefly aporphines and oxoaporphines. To our knowledge, there are no reports of oxophoebine possessing antibacterial activity. The second major constituent detected, reticuline, is an aporphine alkaloid. Medicinal activities attributed to reticuline include antibacterial and antiviral activity [18] . These results suggest the antibacterial activity detected (Table 1) is at least partially attributable to reticuline. Our finding that A. squamosa activity is attributable to an alkaloid(s) could potentially limit its use as a food additive, as these compounds typically have a bitter taste. This factor would be less problematic in foods containing fat, sugar and / or salt, where bitterness is less perceptible [19] .
MBCs were determined as a preliminary assessment of bactericidal activity (Table 1) . Values obtained were within 4-fold of MICs for C. jejuni and B. cereus, suggesting possible bactericidal activity. MBCs against the other 2 species were much higher, indicating the fraction is bacteriostatic against S. aureus and L. monocytogenes. In subsequent time-kill assays, fractionated extract decreased CFU numbers of C. jejuni and B. cereus by more than 99.9% ( Figure 1 ). Again, this was suggestive of bactericidal activity [20] . Subsequent light microscopic analysis of treated bacteria showed that, unlike other plant-derived antibacterials [21, 22] , A. squamosa extract does not induce aggregation of bacterial cells. This indicates that the decreases in CFU numbers in Figure 1 are indeed due to bactericidal activity, and not cells clumping together. It is not clear why the extract is just bacteriostatic against S. aureus and L. monocytogenes. The failure of an otherwise bactericidal agent to induce killing is sometimes an indication that the bacterial strain has a defective autolytic system [23] , but this is not the case here because gentamicin was bactericidal against all the test strains (Table 1) .
Studies assessing stability during storage show solutions of the fractionated extract rapidly lose activity at room temperature (30°C; Figure 2 ). Even in powder form, the fraction's activity decreased by 50% against C. jejuni and 94% against S. aureus during 11 weeks storage at 30°C. Activity is comparatively stable during storage at refrigeration temperature (4°C), with solutions retaining full activity for up to 3 weeks ( Figure 2 ). In powder form the fraction is more stable still, maintaining full activity against both bacterial species during 11 weeks storage at 4°C. This leaves open the possibility that A. squamosa extract or its constituents could be used as additives in perishable (short shelf-life) refrigerated foods. Additional studies to determine the stability of the fractionated extract to heat-treatment ( Figure 3 ) indicate its antibacterial activity is heat-labile, with loss of activity occurring in a temperaturedependent manner. Minimal loss of activity was observed following incubation at 37°C, so development of the fraction for use in medicine remains a possibility. Antibacterial activity decreased by 75% following treatment at 63°C though, and 87.5% following treatment at 121°C. Effectively, this rules out the possibility of using the fraction as an additive in foods where it would need to be incorporated prior to cooking or thermal processing. Similar findings have been reported for the active constituents of numerous other plant species [24, 25] , suggesting heat-lability may be a universal problem for plant-origin antimicrobials. In conclusion, results from this study indicate A. squamosa extract has broad-spectrum antibacterial activity against foodborne pathogens. This activity is bactericidal against B. cereus and C. jejuni but, unlike extracts from other plant species [13] , A. squamosa takes hours rather than minutes to exert this effect. Clearly, this rate of cell killing is not sufficiently rapid for A. squamosa to be useful as a food sanitizer. Heat-lability represents another limitation. If A. squamosa was developed as a food additive, it could only be employed in perishable refrigerated foods. In light of these findings, and taking into account the need to conserve antibacterial agents of potential therapeutic value, efforts should initially focus on developing A. squamosa for use in modern medicine. Additional studies are therefore underway in our laboratory to determine the mechanism of action of A. squamosa.
Experimental
Bacteria: B. cereus ATCC 1178, L. monocytogenes ATCC 19111, S. aureus ATCC 6538, C. jejuni ATCC 29428, E. coli ATCC 25922, and S. ser. Typhimurium ATCC 13311 were obtained from the American Type Culture Collection. C. jejuni was cultured on brucella agar supplemented with 62.5 mg/L each of ferrous sulfate, sodium metabisulfite and sodium pyruvate. L. monocytogenes was cultured on tryptic soy yeast extract agar, and the remaining bacteria were cultured on Mueller-Hinton agar. C. jejuni was incubated at 42°C for 48 h in microaerobic conditions (5% O 2 , 10% CO 2 , and 85% N 2 ), and the other bacteria were incubated at 37°C for 24 h in aerobic conditions.
Plant material, extraction, and fractionation:
A. squamosa leaves were collected in Maha Sarakham (Thailand) in September 2009 and a voucher specimen (Achara no. 03-10) was deposited at the Walairukavej Botanical Research Institute. Total ethanol extract was prepared using the optimized method described previously [26] . In all, 17.30 g total extract was obtained from 200 g dried material. Ten grams of this extract were added to a 4x60 cm column packed with silica gel 60 (63-200 μm, 300 g; Merck). The column was eluted with an increasing polarity gradient (ethanol:hexane) at a flow rate of 3 mL/min. Fractions (20 mL/tube) were collected as follows. Tubes 1-60 were obtained using 15% ethanol:85% hexane, tubes 61-134 using 30% ethanol:70% hexane, tubes 135-139 using 70% ethanol:30% hexane, and tubes 160-200 using 100% ethanol. Fractions were analyzed by thin layer chromatography on silica gel 60 F 254 TLC aluminum sheets (Merck). Sheets were spotted with 5 μL of liquid from the different tubes and allowed to air-dry prior to observation under visible light. Fractions with the same retention time were combined, and solvents removed by rotary evaporation at 50°C under pressure. This yielded eight fractions: I (tubes 1-7; 0.23 g), II (tubes 8-31; 0.92 g), III (tubes 32-47; 0.87 g), IV (tubes 48-54; 0.23 g), V (tubes 55-69; 0.09 g), VI (tubes 70-88; 0.19 g), VII (tubes 89-113; 0.35 g) and VIII (tubes 114-200; 4.75 g). Fraction VIII, which was identified as having the broadest spectrum of activity (see Supplementary data) when tested by disc diffusion [27] , was used in all subsequent experiments.
MIC and MBC assays:
MICs were determined using the broth microdilution method described previously with gentamicin as the reference standard [26] . MBCs were determined using the microtiter trays from the MIC assay [20] . The entire volume of liquid (~100 µL) was aspirated from wells with no visible growth, and streaked across the surface of agar plates. After incubation, colonies were counted and the endpoint determined by identifying the lowest concentration to cause a 99.9% decrease in CFU numbers. All experiments were performed in duplicate to verify reproducibility of results.
LC/DAD-APCI/MS analysis:
The LC system comprised of a series of Agilent Technologies 1100 diode array detector (DAD), autosampler, binary pump and on-line vacuum degasser. A Luna-C18 (150x2.0 mm, i.d. 3.0 µm; Phenomenex) was used as LC-MS analysis column. The mobile phase A was acetonitrile, while B was milli-Q water. The gradient was performed at 0.2 mL/min with an initial condition of 30% mobile phase A and 70% mobile phase B for 20 min. Peaks were simultaneously determined at 210 nm. Mass spectrometric analyses were performed on a quadrupole MS detector with multi-mode ion source, electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) interface from Agilent (Agilent Technologies 1100 series). The full mass scanning range was m/z 50 to 800. Constituents were identified by comparing the mass spectra of samples with earlier publications on the Annonaceae family [28, 29] .
Time-kill assays:
Bacterial species exhibiting 99.9% decreases in CFU numbers in the MBC assay were selected for further analysis by time-kill assay [20] and light microscopy [22] . Sterile glass bottles containing 20 mL broth only, broth with 2% (v/v) DMSO, and broth with 1xMBC or 2xMBC extract were inoculated so as to contain ~5x10 5 CFU/mL bacteria.
Inoculated bottles were incubated with shaking (100 rpm/min) at 42°C under microaerobic conditions (for C. jejuni) or 37°C under aerobic conditions (for B. cereus). CFU counts were determined by removing 1 mL samples, preparing a dilution series in 0.1% (w/v) sterile peptone water (10 -1 -10 -6 ) and plating this out (ten 20 µL drops per dilution) on agar. Time-kill assays were performed in duplicate to verify reproducibility of results. Since some classes of phytochemical induce aggregation of bacterial cells, light microscopy studies were performed to determine if decreases in CFU numbers detected in time-kill assays were due to bactericidal activity or cell aggregation. This was performed as described previously [22] but, to mirror conditions in the time-kill assay more precisely, a starting cell density of ~5 x 10 5 CFU/mL was used. Bacteria were examined by standard brightfield light microscopy (x1000; DP 70; Olympus).
Stability during storage at room and refrigeration temperature:
Sterile, foil-wrapped glass bottles were prepared containing 5 mL aqueous solutions of 4 mg/mL fractionated extract or 4 mg fractionated extract powder. These bottles were stored at room (30°C) or refrigeration temperature (4°C). Stability testing of solutions was performed at a range of time intervals (t= 0, 1, 2, 3, 5, 7, 9 and 11 weeks), while aliquots of the powder were tested at 0 and 11 weeks only. All samples were tested in quadruplicate. Stability was assessed by determining MICs, and assays were performed twice to verify reproducibility of results.
Stability to heat treatment: Sterile 5 mL solutions of 4 mg/mL fractionated extract were prepared as before. The bottles were subjected to different treatments, simulating conditions encountered by antibacterial agents used therapeutically or as food additives [37°C for 24 h (human body), 63°C for 30 min (pasteurization), and 121°C for 15 min (sterilization)]. Bottles stored at 4°C for 24 h were used as controls. All samples were allowed to return to room temperature prior to testing, and samples were tested in quadruplicate. Stability was assessed by determining MICs, and assays were performed twice to verify reproducibility of results.
Supplementary data: Disc diffusion assay results for fractions I to VIII and the six test species of bacteria are available online.
